MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-18-0035315
Cannosa Pharmaceuticals Private Limited
Cannosa Pharmaceuticals Private Limited - chemicals in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Mumbai
ROC office
About Cannosa Pharmaceuticals Private Limited
Data last updated:
Cannosa Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 05 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2020PTC345413.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹10,000. It is led by directors Abhishek Anil Yadav and Anil Devraj Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 17 Gajmukh Chs Kandivali West Opp. S No. 157 Plot Ad 4 Charkop, Mumbai, Maharashtra, India – 400067.
Cannosa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0035315).
Company details
CIN U24299MH2020PTC345413
Registration Number 345413
Incorporation Date 05 September 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0035315
Recognitions & Rankings of Cannosa Pharmaceuticals
Contact details
Cannosa Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA – 17 Gajmukh Chs Kandivali West Opp. S No. 157 Plot Ad 4 Charkop, Mumbai, Maharashtra, India – 400067
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
To see the full contact details of Cannosa Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cannosa Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Cannosa Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cannosa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cannosa Pharmaceuticals Private Limited
Cannosa Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Anil Yadav Also directs: Kelmme Technologies Private Limited | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
| Anil Devraj Yadav | Director | 05 Sep 2020 | 6 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Cannosa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cannosa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cannosa Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Cannosa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cannosa Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Abhishek Anil Yadav was appointed as Director on 05 Sep 2020.
AGM
Cannosa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cannosa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Abhishek Anil Yadav was appointed as Director.
Appointed
Anil Devraj Yadav was appointed as Director.
Incorporation
05 Sep 2020
Cannosa Pharmaceuticals Private Limited was registered on 05 Sep 2020 with Roc Mumbai I & aged 6 years 1 month as per MCA records.
Frequently asked questions
Cannosa Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 05 September 2020 (6+ years old) and is registered under CIN U24299MH2020PTC345413.
Cannosa Pharmaceuticals has 2 current directors:
- Abhishek Anil Yadav - Director
- Anil Devraj Yadav - Director
The latest financial statements of Cannosa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cannosa Pharmaceuticals is U24299MH2020PTC345413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cannosa Pharmaceuticals was incorporated on 05 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Abhishek Anil Yadav was appointed as Director on 05 Sep 2020. Anil Devraj Yadav was appointed as Director on 05 Sep 2020.
Yes, Cannosa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0035315).
The registered office of Cannosa Pharmaceuticals is at A – 17 Gajmukh Chs Kandivali West Opp. S No. 157 Plot Ad 4 Charkop, Mumbai, Maharashtra, India – 400067.
Cannosa Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Cannosa Pharmaceuticals can be reached at its registered office: A – 17 Gajmukh Chs Kandivali West Opp. S No. 157 Plot Ad 4 Charkop, Mumbai, Maharashtra, India – 400067.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages